Cenobamate Approval Status
FDA Approved: No
Generic name: cenobamate
Company: SK Life Science, Inc.
Treatment for: Seizures
Cenobamate is a sodium channel blocker in development for the treatment of partial-onset seizures in adult patients.
Development Status and FDA Approval Process for cenobamate
|Feb 4, 2019||SK Life Science Announces FDA Acceptance of NDA Submission for Cenobamate, an Investigational Antiepileptic Drug|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.